IL13 and irritable bowel syndrome: Our results displayed a significantly reduced IL-10 release in PI-IBS patients compared to healthy controls (Fig 1c) and a tendency to a decreased IL-13 release (Fig 1a) after E. limosum stimulation, which indicates a down-regulation of the anti-inflammatory immune response.